Takeda Pharmaceutical Company Limited
FDA inspection history in Yodogawa-Ku, Japan, 2010 to 2019
- 3
- Form 483s
Every document, by year
- Form 483
2010: one Form 483; 2015: one Form 483; 2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2010One Form 483, at Yodogawa-Ku, Japan.
- 2015One Form 483, at Yodogawa-Ku, Japan.
- 2019One Form 483, at Yodogawa-Ku, Japan.
- 2019The longest 483 on file: 4 observations over 5 pages at Yodogawa-Ku, Japan.
Cited most
Across all Takeda Pharmaceutical Company Limited observations on file
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.194Laboratory records2
- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Takeda Pharmaceutical Company Limited file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Yodogawa-Ku, Japan
Three Form 483s · 2010 to 2019 · 8 observations
Latest: Form 483, Aug 9, 2019 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-08-09 | 483 Form 483 | Yodogawa-Ku, Japan | 4 | $99 |
| 2015-09-18 | 483 Form 483 | Yodogawa-Ku, Japan | 2 | $99 |
| 2010-09-14 | 483 Form 483 | Yodogawa-Ku, Japan | 2 | $99 |
Investigators on these documents
FEI number 3002808311 · most recent document Aug 9, 2019
About Takeda Pharmaceutical Company Limited
How many FDA Form 483s has Takeda Pharmaceutical Company Limited received?
FDA Intel has 3 Form 483s on file for Takeda Pharmaceutical Company Limited; the most recent is dated Aug 9, 2019.
When was Takeda Pharmaceutical Company Limited last inspected by FDA?
The most recent FDA inspection document on file for Takeda Pharmaceutical Company Limited is a Form 483 dated Aug 9, 2019, for the site in Yodogawa-Ku, Japan.
What did FDA cite at Takeda Pharmaceutical Company Limited?
The regulations cited most in the observations on file for Takeda Pharmaceutical Company Limited are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.194 (Laboratory records), 2 times; 21 CFR 211.100(b) (Written procedures; deviations), 1 time.